Concepedia

Jennifer Nielsen Kahn

JN

Statistics

Publications

28

Citations

1.6K

H-Index

23

Active since

2005

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Rutgers, The State University of New Jersey

MSD (Spain)

Merck Canada Inc. (Canada)

Scynexis (United States)

Jennifer Nielsen Kahn is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, mycology, and drug discovery.

Publications per year

2005–2021

28

Publications

28

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical <i>Candida</i> sp. Isolates

S. Park, Rosemarie Kelly, Jennifer Nielsen Kahn et al. · Antimicrobial Agents and Chemotherapy · 2005 · 432 citations

, , +17

Acquired Echinocandin Resistance in a <i>Candida krusei</i> Isolate Due to Modification of Glucan Synthase

Jennifer Nielsen Kahn, Guillermo García‐Effrón, Ming‐Jo Hsu et al. · Antimicrobial Agents and Chemotherapy · 2007 · 118 citations · Full text

, , +17

Using CRISPR-Cas9-mediated genome editing to generate C. difficile mutants defective in selenoproteins synthesis

Kathleen N. McAllister, Laurent Bouillaut, Jennifer Nielsen Kahn et al. · Scientific Reports · 2017 · 106 citations · Full text

, , +17

Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis

Paul A. Mann, Catherine A. McLellan, Sandra Koseoglu et al. · ACS Infectious Diseases · 2014 · 85 citations · Full text

, , +17

PAP Inhibitor with In Vivo Efficacy Identified by Candida albicans Genetic Profiling of Natural Products

Bo Jiang, Deming Xu, John Allocco et al. · Chemistry & Biology · 2008 · 82 citations

, , +17

1–5 of 28